Negative regulation of caspase-3 expression in the neonatal cerebral cortex by alpha2A-adrenoceptors

P N Men'shanov1, A V Bannova, F A Il'inykh

  • 1Laboratory of Functional Neurogenomics, Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk.

Insights

Antisense oligonucleotides targeting alpha2A-adrenoceptors increase apoptosis-related caspase-3 in newborn rat brains. This effect, linked to low adrenoceptor expression, can be reversed by clonidine, an adrenoceptor stimulator.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Alpha2A-adrenoceptors play a role in regulating neuronal function.
  • Apoptosis, or programmed cell death, is a critical process in brain development.
  • Caspase-3 is a key enzyme executing apoptotic pathways.

Purpose of the Study:

  • To investigate the effect of alpha2A-adrenoceptor antagonism on caspase-3 expression in the developing brain.
  • To explore the role of alpha2A-adrenoceptors in regulating apoptosis in newborn rats.
  • To determine if clonidine can counteract the effects of alpha2A-adrenoceptor blockade.

Main Methods:

  • Antisense oligonucleotides were used to inhibit alpha2A-adrenoceptors in newborn rat cerebral cortex.
  • Messenger RNA (mRNA) levels of caspase-3 were quantified using reverse polymerase chain reaction (RT-PCR).
  • Protein levels of caspase-3 were measured via immunoblotting assay.
  • Clonidine, an alpha2-adrenoceptor agonist, was administered to assess its modulatory effect.

Main Results:

  • Inhibition of alpha2A-adrenoceptors led to increased mRNA and protein levels of caspase-3.
  • This increase in caspase-3 was observed in the cerebral cortex of newborn rats.
  • Administration of clonidine reversed the observed increase in caspase-3, confirming the role of alpha2A-adrenoceptors.
  • The findings suggest a link between low alpha2-adrenoceptor expression and enhanced apoptosis.

Conclusions:

  • Antagonism of alpha2A-adrenoceptors upregulates caspase-3, a key apoptotic protease, in the neonatal rat brain.
  • This effect is mediated by the reduced expression of alpha2A-adrenoceptors.
  • Clonidine can restore normal caspase-3 levels, highlighting the therapeutic potential of targeting alpha2A-adrenoceptors in conditions involving altered apoptosis.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...